Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,915 | -120,855 | -154,154 | -213,913 | -164,826 |
| Depreciation Amortization | 8,008 | 9,364 | 11,107 | 11,418 | 10,705 |
| Accounts receivable | -19,341 | 4,475 | 12,551 | -5,380 | 768 |
| Other Working Capital | -25,096 | -8,127 | -12,519 | -715 | 36,373 |
| Other Operating Activity | 3,567 | 34,952 | 14,790 | 29,189 | 440 |
| Operating Cash Flow | $-65,777 | $-80,191 | $-128,225 | $-179,401 | $-116,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,165 | N/A | 2,902 | -2,928 | -15,946 |
| Net Acquisitions | 8,956 | N/A | N/A | -20,000 | N/A |
| Purchase Sale Intangibles | N/A | -15,000 | -5,000 | N/A | -400 |
| Other Investing Activity | 0 | -15,000 | -5,005 | 0 | 56,460 |
| Investing Cash Flow | $10,121 | $-15,000 | $-2,103 | $-22,928 | $40,514 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 28,000 | 5,000 | 7,000 |
| Debt Issued | -75 | 43,670 | 14,529 | 47,112 | N/A |
| Debt Repayment | -5,561 | -51,000 | -50,375 | N/A | -10,450 |
| Common Stock Issued | 3,959 | 22,225 | 24,800 | 6,723 | 9,679 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,105 | N/A |
| Dividend Paid | -664 | -4,710 | -8,768 | -8,780 | -8,780 |
| Other Financing Activity | 79,783 | 60,456 | 24,553 | 26,369 | 151,545 |
| Financing Cash Flow | $77,442 | $70,641 | $32,739 | $75,319 | $148,994 |
| Beginning Cash Position | 58,815 | 83,365 | 180,954 | 307,964 | 234,996 |
| End Cash Position | 80,601 | 58,815 | 83,365 | 180,954 | 307,964 |
| Net Cash Flow | $21,786 | $-24,550 | $-97,589 | $-127,010 | $72,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,777 | -80,191 | -128,225 | -179,401 | -116,540 |
| Capital Expenditure | N/A | N/A | -3,098 | -3,055 | -15,946 |
| Free Cash Flow | -65,777 | -80,191 | -131,323 | -182,456 | -132,486 |